| Year |
Citation |
Score |
| 2020 |
Tököli A, Nyitray L, Monostori É, Czibula Á, Simon MA, Martinek T, Wéber E, Bartus É, Mag B, Szakonyi G. Proteomimetic surface fragments distinguish targets by function Chemical Science. DOI: 10.1039/D0Sc03525D |
0.354 |
|
| 2017 |
Bartus É, Hegedüs Z, Wéber E, Csipak B, Szakonyi G, Martinek TA. De Novo Modular Development of a Foldameric Protein-Protein Interaction Inhibitor for Separate Hot Spots: A Dynamic Covalent Assembly Approach. Chemistryopen. 6: 236-241. PMID 28413758 DOI: 10.1002/Open.201700012 |
0.347 |
|
| 2012 |
Jensen JM, Ismat F, Szakonyi G, Rahman M, Mirza O. Probing the putative active site of YjdL: an unusual proton-coupled oligopeptide transporter from E. coli. Plos One. 7: e47780. PMID 23110099 DOI: 10.1371/Journal.Pone.0047780 |
0.654 |
|
| 2012 |
Linka B, Szakonyi G, Petkovits T, Nagy LG, Papp T, Vágvölgyi C, Benyhe S, Ötvös F. Homology modeling and phylogenetic relationships of catalases of an opportunistic pathogen Rhizopus oryzae. Life Sciences. 91: 115-26. PMID 22749862 DOI: 10.1016/J.Lfs.2012.06.016 |
0.313 |
|
| 2011 |
Saidijam M, Bettaney KE, Leng D, Ma P, Xu Z, Keen JN, Rutherford NG, Ward A, Henderson PJ, Szakonyi G, Ren Q, Paulsen IT, Nes I, Kroeger JK, Kolsto AB. The MFS efflux proteins of gram-positive and gram-negative bacteria. Advances in Enzymology and Related Areas of Molecular Biology. 77: 147-66. PMID 21692369 DOI: 10.1002/9780470920541.Ch4 |
0.567 |
|
| 2009 |
Tanabe M, Szakonyi G, Brown KA, Henderson PJ, Nield J, Byrne B. The multidrug resistance efflux complex, EmrAB from Escherichia coli forms a dimer in vitro. Biochemical and Biophysical Research Communications. 380: 338-42. PMID 19171121 DOI: 10.1016/J.Bbrc.2009.01.081 |
0.64 |
|
| 2009 |
Henderson PJF, Suzuki S, Ma P, Saidijam M, Bettaney KE, Szakonyi G, Rutherford NG, Patching SG, Hope RJ, Roach PCJ, Shimamura T, Yajima S, Carpenter EP, Weyand S, Cameron AD, et al. Structural genomics of bacterial membrane transport proteins Acta Crystallographica Section a Foundations of Crystallography. 65: s28-s28. DOI: 10.1107/S0108767309099516 |
0.725 |
|
| 2007 |
Szakonyi G, Leng D, Ma P, Bettaney KE, Saidijam M, Ward A, Zibaei S, Gardiner AT, Cogdell RJ, Butaye P, Kolsto AB, O'reilly J, Hope RJ, Rutherford NG, Hoyle CJ, et al. A genomic strategy for cloning, expressing and purifying efflux proteins of the major facilitator superfamily. The Journal of Antimicrobial Chemotherapy. 59: 1265-70. PMID 17412722 DOI: 10.1093/Jac/Dkm036 |
0.74 |
|
| 2006 |
Saidijam M, Benedetti G, Ren Q, Xu Z, Hoyle CJ, Palmer SL, Ward A, Bettaney KE, Szakonyi G, Meuller J, Morrison S, Pos MK, Butaye P, Walravens K, Langton K, et al. Microbial drug efflux proteins of the major facilitator superfamily. Current Drug Targets. 7: 793-811. PMID 16842212 DOI: 10.2174/138945006777709575 |
0.752 |
|
| 2005 |
Saidijam M, Bettaney KE, Szakonyi G, Psakis G, Shibayama K, Suzuki S, Clough JL, Blessie V, Abu-Bakr A, Baumberg S, Meuller J, Hoyle CK, Palmer SL, Butaye P, Walravens K, et al. Active membrane transport and receptor proteins from bacteria. Biochemical Society Transactions. 33: 867-72. PMID 16042616 DOI: 10.1042/Bst0330867 |
0.715 |
|
| Show low-probability matches. |